MedTrace Logo

Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients

NCT04480398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2020-07-22

No results posted yet for this study

Summary

Coronavirus disease 2019 (Covid-19) has been declared global emergency with immediate safety, preventative and curative measures to control the spread of virus. Confirmed cases are treated with clinical management as they are diagnosed but so far, there is no effective treatment or vaccine yet for Covid-19.

With recommended guidelines of AYUSH Ministry, India, the use of Ayurveda for Covid-19 has increased; however, its efficacy and safety in Covid-19 confirmed patients remain unclear.

Present study examined the efficacy and safety of one of the recommended Ayurveda drug (Guduchi Ghan Vati) compared with standard care for patients with asymptomatic Covid-19 patients.

Conditions

  • Covid19
  • Asymptomatic Condition

Interventions

DRUG

Guduchi Ghan Vati

Guduchi Ghan Vati is an Ayuvedic classical preparation which is prepared from aqueous of extract of Tinospora cordifolia.

Sponsors & Collaborators

  • Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

    collaborator OTHER

  • Samta Ayurveda Prakoshtha, India

    collaborator UNKNOWN

  • Aarogyam UK

    lead OTHER

Principal Investigators

  • Parashar Sharma · Samta Ayurveda Prakoshtha

  • Jaydeep Joshi · Aarogyam UK

  • Neha Sharma · Aarogyam UK

  • Abhimanyu Kumar · Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-12
Primary Completion
2020-06-15
Completion
2020-07-03

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04480398 on ClinicalTrials.gov